● ELAB shares fell 12.73% following the company's mid-August announcement of an anticipated reverse stock split.
Cumberland Pharmaceuticals (NASDAQ:CPIX) jumped 10.97% to close near $8.70, pushing the specialty pharmaceutical company to fresh 52-week-high territory and capping a powerful multi-month advance. The rally follows a transformative July transaction that recapitalized theBusinessand reoriented its strategy toward clinical development.
DeFi Development Corp. (NASDAQ:DFDV) climbed 11.98% in the latest session, a move that put the Solana-focused treasury company back among the market's more active crypto-adjacent names. For a stock whose value tracks the price of a single digital asset almost as closely as it …
● DKS shares fell roughly 31% after second-quarterEarnings Per Sharedropped about 26% from a year earlier and management cut its fiscal 2026 adjusted EPS outlook to roughly $11 to $12.
Ginkgo Bioworks (NYSE:DNA) surged 11.21% in a session that stood out mainly because the synthetic-biology company has spent much of 2026 grinding lower. The bounce came just weeks after a disappointing second-quarter report that had pressured the shares, suggesting the move was as much …
1. INFLATION: July PCE Runs Hot at 3.7% Annually as Core Matches Forecasts; GDP, Durable Goods, and Personal Income All Beat Estimates
ClearOne, Inc. (NASDAQ:CLRO), a small-cap audio-conferencing hardware maker, jumped 11.98% as traders continued to reassess a stock that has been transformed by a pending reverse merger. What was once a sleepy communications-equipment name has become a speculative vehicle for a very different business, and …
ClearOne, Inc. (NASDAQ:CLRO), a small-cap audio-conferencing hardware maker, jumped 11.98% as traders continued to reassess a stock that has been transformed by a pending reverse merger. What was once a sleepy communications-equipment name has become a speculative vehicle for a very different business, and …
Compugen (NASDAQ:CGEN), an Israel-based cancer-immunotherapy company, rose 10.81% to about $2.87, roughly doubling from a year earlier and reclaiming attention among biotech traders. The Tel Aviv-headquartered firm has quietly built aBusinessmodel that blends its own clinical programs with lucrative partnerships alongside AstraZeneca and Gilead …
Comstock Holding Companies (NASDAQ:CHCI), an asset-light real-estate services and development firm centered on the Washington, D.C., region, rallied 10.53% as investors digested a blockbuster quarter and an emerging story about data-center power. The move suggested the market is beginning to look at Comstock as …